Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Exparel patent litigation status 2026?Where is klonopin manufactured?Current street price adderall 2025 or 2026?Pacira biosciences exparel patent status 2026?Tretinoin cream in mexico?
See the DrugPatentWatch profile for Incruse
“Incruse” is the brand name for the COPD medicine umeclidinium.
Yes. Any generic product sold for “Incruse” uses the same active ingredient name: umeclidinium (it may be listed as umeclidinium bromide on labels).
Umeclidinium is used to help manage chronic obstructive pulmonary disease (COPD), typically to reduce symptoms by acting as a long-acting bronchodilator.
If you share the full label name (including strength, e.g., “62.5 mcg,” and whether it’s an inhalation powder), I can tell you the exact generic naming format used on that product.
Other Questions About Incruse :